MedPath

Research on Association Between Selenium Deficiencies and Change of Thyroid Function

Conditions
Selenium Deficiency
Interventions
Diagnostic Test: detection of serum selenium
Registration Number
NCT03448588
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

As one of the essential micronutrients, selenium has important biological functions. However, an effective and convenient method for evaluation of selenium nutritional status has not yet been established. Previous literature has disclosed effect of selenium deficiency on inactivating glutathion peroxidase and deiodinase, which may cause decreased conversion from thyroxine ( T4) to triiodothyronine (T3). A case-control study is designed to demonstrate the association between selenium deficiency and abnormally elevated T4 or T4/T3, which may provide more clues for establishing effective selenium assesment methods.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • with normal free triiodothyronine( FT3), free thyroxine (FT4) and thyroid-stimulating hormone (TSH).
  • without thyroid hormone replacement therapy
  • without medical history of thyroid surgery
  • without iodine radiotherapy;
Exclusion Criteria
  • acute critical illness in the latest 1 year;
  • weight fluctuation by more than 5% in the latest 3 months;
  • eating disorders
  • neuropsychological disorders
  • allergy to corn or yeast
  • fail to give informed consents.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
group with normal T4 level or T4/T3detection of serum seleniumparticipants with T4 within 4.3-12.5ug/dl and ratio of T4/T3(T4(ug/dl)/T3 (ng/ml)) ≤7.52, which are considered to be normal T4 level and T4/T3.
group with elevated T4 level or T4/T3detection of serum seleniumparticipants with T4 more than 12.5ug/dl and ratio of T4/T3(T4(ug/dl)/T3 (ng/ml)) \> 7.52, which are considered to be elevated T4 level and T4/T3.
Primary Outcome Measures
NameTimeMethod
between-group difference in serum seleniumup to 24 weeks

comparison of the mean serum selenium between the two groups

Secondary Outcome Measures
NameTimeMethod
between-group difference in serum deiodinase activityup to 24 weeks

comparison of the mean deiodinase activity between the two groups

between-group difference in erythrocyte glutathione peroxidase activityup to 24 weeks

comparison of the mean erythrocyte glutathione peroxidase activity between the two groups

Trial Locations

Locations (1)

Peking Union Medical College Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath